Camille D. Samuels

Camille D. Samuels discloses dealings in 2 companies, chiefly Kythera Biopharmaceuticals Inc and Paratek Pharmaceuticals, Inc. The record holds 38 filings, for trades running from 15 May 2006 to 1 October 2015.

Market trades split into 1 purchase and 13 sales (€109k). The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants and 3 option exercises. Since January 2015: no purchases and 13 sales on the market.

The latest filing, published on 2 October 2015, reports a transaction in Kythera Biopharmaceuticals Inc. The latest purchase dates back some time: it was published 7,467 days ago, on 15 May 2006. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.